This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
One-year course of studies leading to a ... The Centre for Traditional Chinese Medicine of the University of ... (12 Jul 2019)
Exercise during pregnancy can give child ... Vitamin D is important to enable calcium to be absorbed into the ... (09 Jul 2019)
Pre-Eclampsia May Carry Long-Term Heart ... Pre-eclampsia is a potentially dangerous condition characterized ... (04 Jul 2019)
Blood pressure drug linked with increased ... A type of blood pressure lowering medication, called a ... (04 Jul 2019)
Adequate intake of milk and dairy products ... An adequate consumption of milk and dairy products at different ... (04 Jul 2019)
Monday, 13 May 2019 19:28

Fracture Risk Tool Is Useful in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy Featured

Rate this item
(0 votes)

The FRAX®tool takes into account certain factors to determine the risk of bone fracture in the general population.

In a Journal of Bone and Mineral Research study, the tool was effective at determining fracture risk for women with breast cancer who were treated with aromatase inhibitors, which cause accelerated bone loss, when combined with bone mineral density measurements.
However, the results also question the practice of considering aromatase inhibitors a “secondary cause of osteoporosis” when the FRAX® tool is used without bone mineral density, because this can lead to over estimation of fracture risk. Nonetheless, it is very important to determine fracture risk in women receiving aromatase inhibitor therapy who will most likely experience bone loss during treatment.

“We hope that our data will help to inform clinical guidelines regarding fracture risk assessment in women with breast cancer, and the incorporation of FRAX® in management algorithms of those receiving aromatase inhibitors,” said lead author Dr. William D. Leslie, of the University of Manitoba, in Canada.


Source: Wiley

Full bibliographic information

Performance of FRAX in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study. Journal of Bone and Mineral Research. DOI:10.1002/jbmr.3726

Read 206 times Last modified on Tuesday, 14 May 2019 16:01

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…